1-3 of 3
Annick Tricot
Close
Sort by
Journal Articles

A Single Autologous Stem Cell Transplant (ASCT) Followed By Two Years of Post-Transplant Therapy Is Safe in Older Recently Diagnosed Multiple Myeloma (MM) Patients. Preliminary Results from the Prospective Phase II Trial (NCT01849783)

Kalyan Nadiminti, MD, Lindsay Dozeman, Annick Tricot, Allyson Schultz, Sheila Ouverson, Fenghuang Zhan, MD PhD, Margarida Silverman, MD, Guido J. Tricot, MD PhD, Yogesh Jethava, MBBS,MDFRCPath,MRCP
Journal: Blood
Blood (2017) 130 (Supplement 1): 4543.
https://doi.org/10.1182/blood.V130.Suppl_1.4543.4543
Published: 2017
Journal Articles

Bortezomib, Dexamethasone, Thalidomide and Melphalan (VDT-Mel) Preparative Regimen in Autologous Stem Cell Transplant (ASCT) Results in a Very High Stringent CR (sCR) Rate in Multiple Myeloma (MM)

Kalyan Nadiminti, MD, Kamal Kant Singh Abbi, MBBS, Annick Tricot, Allyson Schultz, Lindsay Dozeman, Sarah L Mott, MS, Fenghuang Zhan, MD PhD, Guido J Tricot, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1971.
https://doi.org/10.1182/blood.V126.23.1971.1971
Published: 2015
Journal Articles

Collection of Peripheral Blood Stem Cells in Patients with Multiple Myeloma after Stem Cell Transplant: A Single Institution Experience

Umang Swami, MD, Lindsay Dozeman, Annick Tricot, Kamal Kant Singh Abbi, MBBS, Guido J Tricot, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5435.
https://doi.org/10.1182/blood.V126.23.5435.5435
Published: 2015